Roxane Laboratories, Inc. announced today the approval of its Abbreviated New Drug Application (ANDA) for Calcium Acetate Capsules, 667mg by the U.S. Food and Drug Administration. The product is available in bottles of 200 capsules for immediate shipment to wholesalers and pharmacies nationwide.
The details can be read here.
No comments:
Post a Comment